Abiopharma

🔍 Lissette Dylan (Director)

Company: Utz Brands, Inc. (UTZ)

Report Date: 2026-04-23

Detailed Transactions and Holdings:

• Acquired 16,927 shares of Class A Common Stock (Direct)
  Date: 2026-04-23 | Code: A | equity_swap_involved: 0 | shares_owned_after: 160,730.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-04-23 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 14,829.00 | Footnotes: F3

Footnotes:

• F1: The shares of Issuer's Class A Common Stock are subject to a restricted stock unit award under the Utz Brands, Inc. 2020 Omnibus Equity Incentive Plan (as amended, the "Plan"). Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
• F2: The restricted stock units vest under the following schedule: subject to the terms of the restricted stock unit award agreement, 100% of the shares subject to the restricted stock units vest on April 23, 2027, subject to the reporting person's continuous service to the Company through such dates and subject to certain conditions detailed in the Plan.
• F3: Reflects shares directly held by a trust for the benefit of the reporting person's youngest child, who shares the reporting person's household. The reporting person disclaims beneficial ownership of the shares held on behalf of his child by this trust, and this report should not be deemed an admission that the reporting person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose.